Carol Ashe
Board Member
Elicio Therapeutics, Inc. (ELTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Elicio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELTX alertsAbout Carol Ashe
Carol Ashe is recorded as Board Member at Elicio Therapeutics, Inc. (ELTX). The newest filing on record that lists Carol Ashe as Board Member at Elicio Therapeutics, Inc. (ELTX) is dated October 9, 2026. Aptose Biosciences Inc. reported in an 8-K filed June 18, 2025 that Carol Ashe resigned as member of the Board, effective June 16, 2025. Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Carol Ashe was appointed Class III Director, effective June 1, 2023. Elicio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Elicio Therapeutics, Inc. includes Robert Connelly (CEO, Chief Accounting Officer and Board Member), Julian Adams (Chairman), Julian Adams, Ph.D. (Chairman and Board Member) and 7 others.
“On June 16, 2025, Carol Ashe notified the Board of Directors (the “Board”) of Aptose Biosciences Inc. (the “Company”) of her intention to resign from her role as a member of the Board effective immediately.”
“Julian Adams, Ph.D., Jay R. Venkatesan, M.D. and Carol Ashe being appointed as Class III directors of the Company whose terms expire at the Company's 2026 annual meeting of stockholders”
Affiliation history
-
Current
Start not stated–present
Last confirmed October 9, 2026
Company network
Leadership on record at Elicio Therapeutics, Inc.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams Chairman
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
- Jay R. Venkatesan Board Member